Preclinical assessment of dual CYP26[A1/B1] inhibitor, DX308, as an improved treatment for keratinization disorders
- J. G.S. Veit
- , Y. Poumay
- , D. Mendes
- , J. Kreitinger
- , L. Walker
- , A. Paquet
- , C. Menigot
- , F. Zolezzi
- , A. S. Paller
- , P. Diaz
- University of Montana
- Universite de Namur
- DermaXon LLC
- Syneos Health France
- Northwestern University
Research output: Contribution to journal › Article › peer-review
4
Scopus
citations